As of 2026-03-23, the Relative Valuation of Abivax SA (ABVX.PA) is (13.79) EUR. This relative valuation is based on P/E multiples. With the latest stock price at 109.40 EUR, the upside of Abivax SA based on Relative Valuation is -112.6%.
The range of the Relative Valuation is (7.71) - (18.93) EUR.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 2.3x - 6.0x | 4.2x |
| Forward P/E multiples | 2.5x - 6.8x | 4.6x |
| Fair Price | (7.71) - (18.93) | (13.79) |
| Upside | -107.0% - -117.3% | -112.6% |
| Date | P/E |
| 2026-03-17 | -34.59 |
| 2026-03-16 | -34.21 |
| 2026-03-13 | -32.30 |
| 2026-03-12 | -32.81 |
| 2026-03-11 | -30.73 |
| 2026-03-10 | -31.69 |
| 2026-03-09 | -30.29 |
| 2026-03-06 | -30.00 |
| 2026-03-05 | -31.63 |
| 2026-03-04 | -31.75 |
| 2026-03-03 | -30.45 |
| 2026-03-02 | -31.79 |
| 2026-02-27 | -32.74 |
| 2026-02-26 | -32.81 |
| 2026-02-25 | -33.83 |
| 2026-02-24 | -34.91 |
| 2026-02-23 | -35.17 |
| 2026-02-20 | -35.87 |
| 2026-02-19 | -35.11 |
| 2026-02-18 | -35.23 |
| 2026-02-17 | -34.47 |
| 2026-02-16 | -34.34 |
| 2026-02-13 | -33.89 |
| 2026-02-12 | -33.19 |
| 2026-02-11 | -31.34 |
| 2026-02-10 | -32.23 |
| 2026-02-09 | -31.31 |
| 2026-02-06 | -30.92 |
| 2026-02-05 | -30.48 |
| 2026-02-04 | -30.35 |
| 2026-02-03 | -30.80 |
| 2026-02-02 | -29.90 |
| 2026-01-30 | -30.25 |
| 2026-01-29 | -30.61 |
| 2026-01-28 | -30.83 |
| 2026-01-27 | -32.23 |
| 2026-01-26 | -32.42 |
| 2026-01-23 | -34.02 |
| 2026-01-22 | -33.19 |
| 2026-01-21 | -32.74 |
| 2026-01-20 | -33.13 |
| 2026-01-19 | -32.23 |
| 2026-01-16 | -32.62 |
| 2026-01-15 | -33.06 |
| 2026-01-14 | -34.47 |
| 2026-01-13 | -33.19 |
| 2026-01-12 | -33.19 |
| 2026-01-09 | -31.60 |
| 2026-01-08 | -31.66 |
| 2026-01-07 | -34.98 |